Expression of CK19 has been used so far as a single marker for the detection of micrometastases in gynecological cancer [11, 13, 22], while a single study has employed another member of the cytokeratin family, the CK20 protein [12]. The gene discussed is KRT20; the disease is female reproductive organ cancer.